Comprehensive Genomic Profiling Testing for Castration‐Resistant Prostate Cancer in Advanced Elderly Patients: A Single‐Center Retrospective Cohort Study
The Prostate2025Vol. 85(12), pp. 1134–1142
Takafumi Fukushima, Keisuke Goto, Yoshinori Nakano, Shinsaku Tasaka, Kyohsuke Iwane, Ryo Tasaka, Kohei Kobatake, Akihiro Goriki, Asuka Toshida, Akiko Abe, Mitsuaki Ishihara, Hikaru Nakahara, Masanori Motonaga, Kentaro Tokumo, Yasutoshi Fujii, Hayes Clair Nelson, Hiroaki Niitsu, Shinya Ohara, Yuji Urabe, Wataru Okamoto, Eiso Hiyama, Koji Arihiro, Takao Hinoi, Nobuyuki Hinata
Abstract
CGP testing appears to offer clinical benefits for patients with CRPC, regardless of age.
Related Papers
- → Three-year analysis to determine prognostic factors affecting success in single-dose methotrexate treatment: a single-center experience(2018)2 cited
- → Liver Transplantation for MELD-Score 40 Patients: Preliminary Results and Single Center Experience.(2014)
- → Can we improve the detection rate of prostate cancer using standard 12‐core TRUS‐guided prostate biopsy? Focused on the location of prostate biopsy(2020)
- → TCT-279: Long Term Outcome After PCI Using Single Or Double Stenting In Diabetic Patients With De Novo Coronary Bifurcation Lesions - Results From A Large Single Center Registry(2009)